Literature DB >> 6980934

Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.

R P Sekaly, H R MacDonald, P Zaech, M Nabholz.   

Abstract

In an attempt to better define the mode of action of TCGF we have investigated the effect of complete removal of TCGF on the cell cycle kinetics of a TCGF-dependent murine CTL cloned line (B6.1). Cells that had been cultured in the presence or absence of TCGF were stained with propidium iodide, a DNA binding dye, and the distribution of DNA content was analyzed by flow cytometry. Results indicated that the proportion of cells entering the S phase of the cell cycle started to decrease 6 hr after removal of TCGF from the culture medium. This fraction continued to decrease as a function of time, and after 30 hr without TCGF 93% of the cells were in the G1 phase of the cell cycle in comparison to 38% in control cultures containing TCGF. Direct evidence that B6.1 cells completed one cell cycle after removal of TCGF before they accumulated in the G1 phase was obtained with a technique combining the use of BUdR, a thymidine analog, and the DNA binding dye Hoechst 33342. When TCGF was added again to cultures of B6.1 cells that were arrested in the G1 phase, the majority of cells entered the S phase in a synchronous fashion after a lag phase of 10 to 12 hr. The duration of this lag phase was independent of the concentration of TCGF used to restimulate quiescent B6.1 cells. However, the number of cells entering S phase 10 hr after re-addition of TCGF was concentration dependent. Additional experiments indicated that the cytolytic activity was not dependent on TCGF, since no decrease in the activity of B6.1 cells was noted after these cells had been deprived of TCGF for up to 30 hr.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980934

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Colony-stimulating factor (CSF) controls proliferation of CSF-dependent cells by acting during the G1 phase of the cell cycle.

Authors:  D H Pluznik; R E Cunningham; P D Noguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

2.  c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.

Authors:  A Lauder; A Castellanos; K Weston
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Prolongation of G1 phase in cultured glioma cells by cis-dichlorodiammineplatinum (II) (CDDP): analysis using bromodeoxyuridine (BrdU)-Hoechst technique.

Authors:  T Morimura
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

4.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

5.  Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.

Authors:  Sabine Francke; Charles G Orosz; Jason Hsu; Lawrence E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

6.  Immunosuppression with glucocorticoids--a possible immunological explanation for interpatient variation in sensitivity: discussion paper.

Authors:  J S Beck; M C Browning
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

7.  Granules of cytolytic T-lymphocytes contain two serine esterases.

Authors:  D Masson; M Nabholz; C Estrade; J Tschopp
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

8.  Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell lines.

Authors:  J M Garland; A Aldridge; J Wagstaffe; T M Dexter
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.